These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16324611)

  • 1. [Study of renal morphology and function in children with nocturnal enuresis. Relationship with sensitivity or resistance to desmopressin].
    Marrero Pérez CL; García Nieto V; Luis Yanes MI
    An Pediatr (Barc); 2005 Dec; 63(6):475-9. PubMed ID: 16324611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
    Kamperis K; Rittig S; Radvanska E; Jørgensen KA; Djurhuus JC
    J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
    Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
    J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis.
    Radvanska E; Kovács L; Rittig S
    J Urol; 2006 Aug; 176(2):764-8; discussion 768-9. PubMed ID: 16813940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathophysiology of monosymptomatic nocturnal enuresis with special emphasis on the circadian rhythm of renal physiology.
    Dossche L; Walle JV; Van Herzeele C
    Eur J Pediatr; 2016 Jun; 175(6):747-54. PubMed ID: 27138767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
    Ikeda H; Watanabe T; Isoyama K
    Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of urine osmolality and other easily detected parameters on the response to desmopressin in the management of monosymptomatic nocturnal enuresis in children.
    Sözübir S; Ergun G; Celik A; Ulman I; Avanoglu A
    Minerva Urol Nefrol; 2006 Jun; 58(2):207-12. PubMed ID: 16767075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
    Van de Walle J; Van Herzeele C; Raes A
    Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmopressin use in pediatric nocturnal enuresis patients: is there a sex difference in prescription patterns?
    Schroeder MK; Juul KV; Mahler B; Nørgaard JP; Rittig S
    Eur J Pediatr; 2018 Mar; 177(3):389-394. PubMed ID: 29260376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of indomethacin on desmopressin resistant nocturnal polyuria and nocturnal enuresis.
    Kamperis K; Rittig S; Bower WF; Djurhuus JC
    J Urol; 2012 Nov; 188(5):1915-22. PubMed ID: 22999686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis.
    Rushton HG; Belman AB; Zaontz MR; Skoog SJ; Sihelnik S
    J Urol; 1996 Aug; 156(2 Pt 2):651-5. PubMed ID: 8683752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmopressin resistant nocturnal polyuria secondary to increased nocturnal osmotic excretion.
    Dehoorne JL; Raes AM; van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2006 Aug; 176(2):749-53. PubMed ID: 16813935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of urine osmolality and ions in the pathogenesis of primary enuresis nocturna and in the prediction of responses to desmopressin and conditioning therapies.
    Unüvar T; Sönmez F
    Int Urol Nephrol; 2005; 37(4):751-7. PubMed ID: 16362593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin response in nocturnal enuresis showing concentrated urine.
    Akagawa S; Tsuji S; Akagawa Y; Yamanouchi S; Kimata T; Kaneko K
    Pediatr Int; 2020 Jun; 62(6):701-704. PubMed ID: 32065484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Efficacy of Tolterodine versus Oxybutynin in the Treatment of Children with Desmopressin-Resistant Enuresis: A Randomized Controlled Clinical Trial.
    Ezodin N; Sarouei M; Khademlo M; Milani SH; Yousefi S; Mohammadjafari H
    Ethiop J Health Sci; 2023 Jul; 33(4):611-620. PubMed ID: 38784212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmopressin response in nocturnal enuresis without nocturnal polyuria in Japanese children.
    Akagawa S; Tsuji S; Akagawa Y; Yamanouchi S; Kimata T; Kaneko K
    Int J Urol; 2021 Sep; 28(9):964-968. PubMed ID: 34169597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.
    Montaldo P; Tafuro L; Rea M; Narciso V; Iossa AC; Del Gado R
    BJU Int; 2012 Oct; 110(8 Pt B):E381-6. PubMed ID: 22313792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term home studies of water balance in patients with nocturnal enuresis.
    Rittig S; Schaumburg H; Schmidt F; Hunsballe JM; Hansen AF; Kirk J; Vestergaard P; Djurhuus JC
    Scand J Urol Nephrol Suppl; 1997; 183():25-6; discussion 26-7. PubMed ID: 9165600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.
    De Guchtenaere A; Vande Walle C; Van Sintjan P; Donckerwolcke R; Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle J
    J Urol; 2007 Dec; 178(6):2635-9; discussion 2639. PubMed ID: 17945291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.